Cannabis Sativa Inc (CBDS)

[RationalOptimist]

I think it's a steal at this price. CBDS licenses the “hi” and “White Rabbit” brands. They have one of the few U.S. patents on a strain of cannabis (Ecuadorian Sativa). They have other “patent pending” trade secret formulas. They have the “hi benefits card.” They have a number of impressive subsidiaries (Wild Earth Naturals, PrestoDoctor, iBudTender, etc.). And now they just received another U.S. patent (#10105343) for “Cannabis based compositions and methods of treating hypertension.” And all this says nothing of their “best in the sector” leadership team.

They also have some serious revenue coming in now too. According to Nasdaq, they reported impressive revenues of $206,474 for the three months ended June 30, 2018, up from an anemic $1,981 reported last year. Revenue for the first half of the year rocketed up to $301,064 from $3,046 last year.

Of course they had to make some substantial investments to get to this point—this is business after all—but what I see today is a savvy team of professionals with decades of expertise laying the foundation for a global company that will go absolute gangbusters with the end of prohibition.

As far as the current stock price, in my opinion CBDS should be up there in the top five of all cannabis stocks.